Axios @axios
Pfizer and BioNTech said today that two doses of their COVID-19 vaccine were significantly less effective at neutralizing the Omicron variant in early lab tests, but a three-dose regimen was more effective. https://t.co/57IVmCbpF7 — PolitiTweet.org